Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Total Assets

Latest as of September 2025: TL17.28 Billion TRY ≈ $387.06 Million USD

Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS total assets. Based on the latest financial reports, Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL) holds total assets worth TL17.28 Billion TRY (≈ $387.06 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Gen Ilac ve Saglik Urunleri Sanayi ve Ti market cap and net worth for the company's overall valuation and market capitalisation.

Total Assets of Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (2018–2024)

Total assets of Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS from 2018 to 2024. This chart illustrates how Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's total assets have evolved over time, based on quarterly financial data. See Gen Ilac ve Saglik Urunleri Sanayi ve Ti stock price for real-time trading data and today's change.

Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS - Asset Composition Analysis

Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Total Assets Breakdown (December 2024)

Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS total assets breakdown as of December 2024. Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's total assets of TL17.28 Billion consist of 47.1% current assets and 52.9% non-current assets.

Asset Category	Amount (TRY)	% of Total Assets
Cash & Equivalents	TL0.00	4.4%
Accounts Receivable	TL1.64 Billion	13.3%
Inventory	TL1.07 Billion	8.7%
Property, Plant & Equipment	TL0.00	0.0%
Intangible Assets	TL963.44 Million	7.8%
Goodwill	TL0.00	0.0%

Asset Composition Trend (2018–2024)

This chart illustrates how Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Gen Ilac ve Saglik Urunleri Sanayi ve Ti (GENIL) liquidity to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's current assets represent 47.1% of total assets in 2024, a decrease from 64.7% in 2018.
Cash Position: Cash and equivalents constituted 4.4% of total assets in 2024, up from 1.4% in 2018.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, an increase from 0.0% in 2018.
Asset Diversification: The largest asset category is accounts receivable at 13.3% of total assets.

Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Competitors by Total Assets

Key competitors of Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS based on total assets are shown below.

Company	Country	Total Assets
GALDERMA GROUP AG NYSE:GALDY	USA	$13.39 Billion
Takeda Pharmaceutical Company Limited F:TKDA	Germany	€15.41 Trillion
Galderma Group N SW:GALD	Switzerland	CHF12.88 Billion
Enzymatica publ AB ST:ENZY	Sweden	Skr149.24 Million
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	China	CN¥13.98 Billion
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	China	CN¥17.01 Billion
Kangmei Pharmaceutical Co Ltd SHG:600518	China	CN¥13.68 Billion
Walvax BioTech SHE:300142	China	CN¥10.50 Billion

Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.35	1.56	2.43
Quick Ratio	1.06	1.24	1.95
Cash Ratio	0.00	0.00	0.00
Working Capital	TL2.22 Billion	TL1.74 Billion	TL827.43 Million

Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS - Advanced Valuation Insights

This section examines the relationship between Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	3.72
Latest Market Cap to Assets Ratio	0.03
Asset Growth Rate (YoY)	10.6%
Total Assets	TL12.31 Billion
Market Capitalization	$351.75 Million USD

Valuation Analysis

Below Book Valuation: The market values Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's assets grew by 10.6% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (2018–2024)

The table below shows the annual total assets of Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS from 2018 to 2024.

Year	Total Assets	Change
2024-12-31	TL12.31 Billion ≈ $275.73 Million	+10.56%
2023-12-31	TL11.13 Billion ≈ $249.39 Million	+202.38%
2022-12-31	TL3.68 Billion ≈ $82.48 Million	+73.75%
2021-12-31	TL2.12 Billion ≈ $47.47 Million	+96.56%
2020-12-31	TL1.08 Billion ≈ $24.15 Million	+92.46%
2019-12-31	TL560.23 Million ≈ $12.55 Million	+35.78%
2018-12-31	TL412.62 Million ≈ $9.24 Million	--

About Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS

IS:GENIL Turkey Drug Manufacturers - Specialty & Generic

Market Cap

$351.75 Million

TL15.71 Billion TRY

Market Cap Rank

#13721 Global

#94 in Turkey

Share Price

TL3.49

Change (1 day)

-5.68%

52-Week Range

TL3.49 - TL199.00

All Time High

TL216.90